McKesson UK’s CEO Toby Anderson steps down with immediate effect


Share post:

McKesson UK‘s CEO Toby Anderson has stepped down from the role with immediate effect after over three years with the company.

Toby joined McKesson UK as CEO in September 2018 moving from health & beauty retailer A.S. Watson Group, where he spent 12 years in various roles. As CEO Asia and Eastern Europe, Toby was responsible for a rapidly growing business with more than 3,300 stores – including 1,500 pharmacies.

Prior to that Toby spent 11 years in a number of senior roles with J. Sainsbury, the second largest grocery retailer in the UK, his last role being Head of Online.

Dominik Meüser from AURELIUS Group said: “We are extremely grateful for the commitment Toby has demonstrated over the years to help us achieve the McKesson vision of becoming the UK’s leading healthcare organization. His leadership, during a period of great uncertainty, has given us the solid foundations we can now build on to deliver sustained success in the future.

“As well as helping to turnaround the profitability of our business, Toby also oversaw our inspirational response to the Covid-19 pandemic, where we ensured that our customers and patients could continue to receive the vital medicines and services they needed.

“We remain focused on delivering great services for our customers and patients across our individual businesses. Through our core businesses – LloydsPharmacy, LloydsPharmacy Clinical Homecare, and AAH – we play a vital role in protecting the health of communities across the country and we have an exciting opportunity to grow and improve our businesses even more over the next few years.”



Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...

Grundon launches maiden UK-wide inhaler recycling programme

Grundon Waste Management has introduced what it claims to be the UK's first verified nationwide inhaler return and...

‘Record fine imposed on hydrocortisone manufacturers for dominant position abuse and 10,000% price increase’

The Competition Appeal Tribunal (CAT) has upheld the Competition and Markets Authority’s (CMA) findings against two pharmaceutical manufacturers...

Vision Report: Legal reforms, adequate funding imperative for success of community pharmacy

Achieving the community pharmacy vision necessitates legal adjustments and additional funding beyond recent boosts, the pharmacy vision document...